Intended Use

PLANET Onco Dose is a standalone software intended to manage, process, display and analyze anatomical and functional images to assist in medical diagnosis, therapy response assessment, contouring of regions of interest, and internal dosimetry computation for radionuclide based therapies.

Technology

The software platform includes modules for image review, fusion, and registration of multimodal anatomical and functional images. It provides contouring, tumor segmentation, therapy response quantification, and internal dosimetry computation using two dose calculation algorithms (voxel S Value dose kernel convolution and local energy deposition). It supports FDA approved isotopes and allows import/export of DICOM data. Partial volume effect correction and reinforced cybersecurity measures are included.

Performance

PLANET Onco Dose underwent performance, functional, algorithmic testing, risk management assessment, and validation under clinically representative conditions. Verification covered workflows such as SIRT, full SPECT/CT pharmacokinetics, hybrid 2D/3D, and single time point pharmacokinetics for molecular radiotherapy. Results demonstrate safety and effectiveness, with dose algorithms showing consistency with Monte Carlo methods.

Predicate Devices

No predicate devices specified

Device Timeline

  • 1

    Submission

    6/20/2024

    8 months
  • 2

    FDA Approval

    3/14/2025

Ready to Sharpen Your Edge?

Join hundreds of your peers who rely on RadAI Slice. Get the essential weekly briefing that empowers you to navigate the future of radiology.

We respect your privacy. Unsubscribe at any time.